Positron emission tomography and computer tomography (PET/CT) in prostate, bladder, and testicular cancers

A. Zouhair, M. Ozsahin, M. Schaffer, S. Albrecht, F. Camus, P. Jichlinski, R. O. Mirimanoff, A. Bischof Delaloye, J. Y. Meuwly, J. O. Prior

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Positron emission computed tomography (PET) is a functional, noninvasive method for imaging regional metabolic processes that is nowadays most often combined to morphological imaging with computed tomography (CT). Its use is based on the well-founded assumption that metabolic changes occur earlier in tumors than morphologic changes, adding another dimension to imaging. This article will review the established and investigational indications and radiopharmaceuticals for PET/CT imaging for prostate cancer, bladder cancer and testicular cancer, before presenting upcoming applications in radiation therapy.

Original languageEnglish
Pages (from-to)2492-2502
Number of pages11
JournalCurrent Medicinal Chemistry
Volume17
Issue number23
DOIs
StatePublished - 20 Aug 2010
Externally publishedYes

Keywords

  • F-18-fluorodeoxyglucose
  • Prostate cancer
  • bladder cancer
  • positron emission tomography
  • testicular cancer

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Positron emission tomography and computer tomography (PET/CT) in prostate, bladder, and testicular cancers'. Together they form a unique fingerprint.

Cite this